Covid-19: Bad for you, but VERY Good for Pfizer

U.S. Health and Human Services Secretary Alex Azar announces ‘historic’ COVID-19 vaccine deal with Pfizer…

Azar, by the way, was a top executive at the pharmaceutical giant Eli Lilly (if he’d worked for Pfizer, we’d be very suspicious. Instead, we’re just normal-suspicious).

U.S. taxpayers will pay Pfizer $1.95 billion to make and deliver 100 million doses of its COVID-19 vaccine from the BNT162 vaccine program if it receives approval from the FDA. Unless there’s some unexpected internal bickering, we’re guessing it will be approved.

The remainder of this article is for members only.

$2 gets you unlimited access to complete articles, archives, images, videos, data, and a variety of additional resources.